OTCPK:GBGPF - Post by User
Comment by
DDobbson Jan 19, 2018 10:48am
166 Views
Post# 27393583
RE:Post-merger pricing
RE:Post-merger pricingWell right now it’s very hard to say but usually the person who buys drops short term and the other stock goes to the asking price. But this is the pot industry. Right now with Cmed trading at 36 just about is not a good sign for the acquisition personally. I don’t think acb would pay anything over 30, at least I hope not. May be taken as a sign as overpaying then we see a short term price drop. This is also a share offer vs a cash offer so dilution may cause a short term dip to??? But again these are the pot stocks and they don’t play by the normal rules.
Personally i I don’t think acb pays over 30 and I don’t think Cmed accepts less than 35.
I hope acb looks at the big picture and realizes that 40,000 patients are not worth a billion dollars when recreational use is so close. Really that’s all Cmed brings to the table that acb doesn’t already have.